Evaluation of histopathological examinations of the cervix diagnosed as "other neoplasms" on the Cancer Information System, Brazil, 2013-2020: a descriptive study.

Autor: Claro IB; Instituto Nacional de Câncer José Alencar Gomes da Silva, Divisão de Detecção Precoce e Apoio a Organização de Rede, Rio de Janeiro, RJ, Brasil., Araújo Junior MLC; Instituto Nacional de Câncer José Alencar Gomes da Silva, Seção Integrada de Tecnologia em Citopatologia, Rio de Janeiro, RJ, Brasil., Ribeiro CM; Instituto Nacional de Câncer José Alencar Gomes da Silva, Divisão de Detecção Precoce e Apoio a Organização de Rede, Rio de Janeiro, RJ, Brasil., Dias MBK; Instituto Nacional de Câncer José Alencar Gomes da Silva, Divisão de Detecção Precoce e Apoio a Organização de Rede, Rio de Janeiro, RJ, Brasil., Tomazelli J; Instituto Nacional de Câncer José Alencar Gomes da Silva, Divisão de Pesquisa Populacional, Rio de Janeiro, RJ, Brasil.
Jazyk: English; Portuguese
Zdroj: Epidemiologia e servicos de saude : revista do Sistema Unico de Saude do Brasil [Epidemiol Serv Saude] 2022 Dec 02; Vol. 31 (3), pp. e2022466. Date of Electronic Publication: 2022 Dec 02 (Print Publication: 2022).
DOI: 10.1590/S2237-96222022000300012
Abstrakt: Objective: to describe and reclassify cervical histopathology test result diagnoses recorded as other neoplasms on the Cancer Information System (SISCAN), Brazil, 2013-2020.
Methods: this was a descriptive study based on diagnoses input to the "other malign neoplasms" field on the SISCAN; a pathologist assessed the diagnoses and reclassified them based on the categories existing on the standardized record form; absolute and relative frequencies of incorrectly recorded diagnoses were calculated.
Results: histopathology test results registered as "other malign neoplasms" accounted for 2.4% (n = 5,778) of all records, 67.4% of which in fact fell into categories already existing on the form, 8.9% were indeed other neoplasms and 24.5% were results not compatible with other neoplasms and were not covered by the form categories, such as benign findings or findings outside the cervix.
Conclusion: the "other malignant neoplasms" field is frequently misused on the SISCAN; the analysis highlighted the need to train professionals to use the system properly, as well as the need to include new categories on the form.
Databáze: MEDLINE